Clinuvel Pharmaceuticals Ltd
F:UR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clinuvel Pharmaceuticals Ltd
F:UR9
|
AU |
|
E
|
Emerson Electric Co
DUS:EMR
|
US |
|
D
|
Deere & Co
F:DCO
|
US |
Dividends
Dividend Yield
Clinuvel Pharmaceuticals Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Clinuvel Pharmaceuticals Ltd
UR9 have increased by 322%.
Payout Ratio
Clinuvel Pharmaceuticals Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
UR9 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
UR9 Price
Clinuvel Pharmaceuticals Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -31% |
| Market Capitalization | 414.7m EUR |
| Shares Outstanding | 49 410 300 |
| Percentage of Shares Shorted |
N/A
|
UR9 Return Decomposition
Main factors of price return
Stock Splits
UR9's latest stock split occurred on Nov 12, 2010
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, UR9 traded at 1.24 per share. Afterward, the share price was about 1.2236.
The adjusted shares began trading on Nov 12, 2010. This was the only stock split in UR9's history.